Investment Research & Advisory Group, Inc.
Position in MRK — Merck & Co., Inc.
CIK 1802136
ATLANTA, GA
Position in MRK
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$308,271
-$440,053 QoQ
Shares Held
2,399
-61.4% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.15%
of 13F equity value
Holder Rank
#3,144
of 3,769 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Investment Research & Advisory Group, Inc. holds $14,457,073 across 8 Drug Manufacturers - General names. MRK ranks #3 (2.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
7,451 | $8,936,953 | |
| 2 | JNJ |
Johnson & Johnson
|
18,355 | $4,661,619 | |
| 3 | MRK |
Merck & Co., Inc.
This page
|
2,399 | $308,271 | |
| 4 | ABBV |
AbbVie Inc.
|
896 | $225,469 | |
| 5 | AMGN |
Amgen Inc
|
493 | $178,525 | |
| 6 | NVO |
Novo Nordisk A S
|
1,115 | $53,453 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
410 | $51,799 | |
| 8 | PFE |
Pfizer Inc
|
1,702 | $40,984 |
All Filings in MRK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $308,271 | 2,399 | Shares | Sole | 2026-07-23 | |
| 2026-03-31 | $748,324 | 6,221 | Shares | Sole | 2026-04-20 | |
| 2025-12-31 | $709,978 | 6,745 | Shares | Sole | 2026-01-20 | |
| 2025-09-30 | $551,839 | 6,575 | Shares | Sole | 2025-10-22 | |
| 2025-06-30 | $515,569 | 6,513 | Shares | Sole | 2025-07-17 | |
| 2025-03-31 | $251,148 | 2,798 | Shares | Sole | 2025-04-21 | |
| 2024-12-31 | $244,919 | 2,462 | Shares | Sole | 2025-01-21 | |
| 2024-09-30 | $279,584 | 2,462 | Shares | Sole | 2024-10-23 | |
| 2024-06-30 | $304,795 | 2,462 | Shares | Sole | 2024-07-30 | |
| 2024-03-31 | $324,860 | 2,462 | Shares | Sole | 2024-04-17 | |
| 2023-12-31 | $268,407 | 2,462 | Shares | Sole | 2024-01-18 | |
| 2023-09-30 | $253,462 | 2,462 | Shares | Sole | 2023-10-19 | |
| 2023-06-30 | $284,090 | 2,462 | Shares | Sole | 2023-07-20 | |
| 2023-03-31 | $261,932 | 2,462 | Shares | Sole | 2023-04-19 | |
| 2022-12-31 | $273,158 | 2,462 | Shares | Sole | 2023-01-31 | |
| 2022-09-30 | $212,027 | 2,462 | Shares | Sole | 2022-10-18 | |
| 2022-06-30 | $250,991 | 2,753 | Shares | Sole | 2022-07-19 | |
| 2022-03-31 | $202,007 | 2,462 | Shares | Sole | 2022-04-25 | |
| 2021-12-31 | $188,687 | 2,462 | Shares | Sole | 2022-01-19 | |
| 2021-09-30 | $184,920 | 2,462 | Shares | Sole | 2021-10-07 | |
| 2021-06-30 | $194,658 | 2,503 | Shares | Sole | 2021-07-29 | |
| 2021-03-31 | $189,795 | 2,462 | Shares | Sole | 2021-04-29 | |
| 2020-12-31 | $201,391 | 2,462 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $204,222 | 2,462 | Shares | Sole | 2020-10-29 | |
| 2020-06-30 | $190,386 | 2,462 | Shares | Sole | 2020-08-04 | |
| 2020-03-31 | $160,958 | 2,092 | Shares | Sole | 2020-04-30 | |
| No filing history on record for this holder in this stock. | ||||||